-
Kenya's economy faces climate change risks: World Bank
-
Spanish actor Javier Bardem leaves his mark on Hollywood Boulevard
-
After three sessions, SpaceX already among world's most valuable companies
-
Surging SpaceX overtakes Amazon to become 5th biggest company
-
BMW downgrades 2026 targets on Mideast war, China woes
-
German court bans McDonald's from making climate claim
-
Campaigners urge G7 chiefs to protect children from AI risks
-
Like father, like son: Prince George to attend Eton College
-
Paris store to part ways with Shein after ownership change
-
US Federal Reserve kicks off first meeting with Warsh as chair
-
How can France-UK mission help reopen Strait of Hormuz?
-
EU to ban plant-based 'steaks' but veggie 'burgers' sizzle on
-
Russian oil producer rations fuel as Ukraine attacks bite
-
EU clears major hurdle on US tariff deal
-
Mideast war peace deal boosts German investor morale
-
Iran says talks on final US deal to begin this week
-
With feasts and music, Kashmiri weddings keep traditions alive
-
French spies drop AI giant Palantir over US overreliance fears
-
India blocks Telegram before retest exam to curb cheating
-
Bank of Japan hikes interest rate to 31-year high
-
Stocks extend rally, oil flat as peace optimism builds
-
Deadline looms for UniCredit's hostile bid for Commerzbank
-
Bank of Japan hikes rate to 31-year high
-
Scientist confronting the rising global threat of mosquitoes
-
India eyes biofertilisers after Mideast war stoked supply fears
-
Most stocks rise, oil flat following peace deal-fuelled rally
-
Toxic 'time bomb' threatens Mekong river basin
-
EU nears finish line on US tariff deal
-
Social networks, online video outweigh traditional media in 2026
-
Trump says Hormuz to 'completely open' after US-Iran peace deal
-
Timeline of Trump-linked resort project in Albania
-
IMF chief warns energy recovery to take time after US-Iran ceasefire
-
Launch 3 Telecom Secures New Lakeland Facility
-
'Start your engines'? Shipping groups wary on Hormuz reopening
-
US-Iran deal met with hope, scepticism in Mideast
-
German working-age population to shrink dramatically: study
-
'For sure': Macron to preach stronger Europe vision at G7 swansong
-
Crude prices plunge, stocks surge on US-Iran peace deal
-
Starbucks Korea to shutter outlets for history lessons after 'Tank Day' fiasco
-
Courts cracking down on error-strewn AI-assisted legal briefs
-
Bitter communion: Cuban priests ordered to ration mass wafers
-
In crisis-hit Cuba, World Cup offers brief respite
-
UK intercepts Russian shadow fleet vessel in Channel
-
London, Tokyo agree $24-bn investment deal
-
Indonesian economy comes up for air but struggles to win back investors
-
Trump says US-Iran deal to be signed Sunday, Hormuz to open after
-
Between Trump and a hard place: Fed chair Warsh to lead first rate meeting
-
High-school drop out to big time crime boss, Venezuela's 'Nino Guerrero'
-
US-Iran deal could be finalised soon, mediator Pakistan says
-
Thousands gather in Thai capital to mourn late princess
Norwegian effectively cured of HIV after transplant from brother
A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.
The patient's brother happened to carry a rare, virus-blocking genetic mutation.
The 63-year-old man, dubbed the "Oslo patient", is the latest in around 10 people worldwide who have gone into long-term remission from HIV after receiving a transplant to treat unrelated blood cancer.
The high-risk procedure normally requires a donor to have a specific mutation of their CCR5 gene, which blocks HIV from entering the body's cells.
Only around one percent of people in northern Europe have the necessary mutation.
The Oslo patient, who had been living with HIV since 2006, was diagnosed with a fatal blood cancer called myelodysplastic syndrome in 2017.
His doctors searched for a donor who would help treat both. When they couldn't find one, they chose the man's elder brother.
However, on the day of the transplant in 2020, the doctors were stunned to discover that the brother carried the CCR5 mutation.
"We had no idea... That was amazing," doctor Anders Eivind Myhre of the Oslo University Hospital told AFP.
- 'Winning the lottery twice' -
The patient said "it was like winning the lottery twice", added Myhre, who was also the lead author of a study describing the case in Nature Microbiology.
Two years after the transplant, the patient stopped taking the anti-retroviral drugs which had been reducing the level of HIV in his body.
The researchers found no trace of the virus in samples of the man's blood, gut and bone marrow.
"For all practical purposes, we are quite certain that he is cured," Myhre said.
Now the Oslo patient, whose name was not revealed, is "having a great time" and has more energy than he knows what to do with, Myhre said.
The painful and potentially dangerous transplant procedure is for people who have both HIV and deadly blood cancer so is not a feasible option for the millions of people living with the virus across the world.
However, researchers believe that studying these rare cases will reveal more about how HIV works in the hope of finding a cure for all patients.
- 'No longer a patient' -
The Oslo patient is the first person to receive a transplant from a family member.
The patient's immune system had been "completely replaced" by the donor's, sqaid study co-author Marius Troseid of the University of Oslo.
It was the first time this had been observed in a cured patient's bone marrow and gut, he told AFP.
Even before the researchers found out the brother had a CCR5 mutation, they had some hope that the Oslo patient's HIV could be cured.
That is because in 2024 it was revealed that the so-called "next Berlin patient" entered long-term remission despite receiving a transplant that did not have two copies of the mutated gene.
The original Berlin patient, Timothy Ray Brown, was the first person declared cured of HIV back in 2008. Patients in London, New York, Geneva, Duesseldorf and elsewhere followed.
Given the Oslo patient's robust health, Troseid suggested that his nickname was no longer suitable.
"The Oslo patient is perhaps no longer a patient. At least he doesn't feel like it," Troseid said.
J.Bondarev--CPN